In 2011 the Food and Drug Administration published a report[1] outlining best practices regarding business process validation in the pharmaceutical industry.
Central to effective CPV is a method with which to identify unwanted process inconsistencies in order to execute corrective or preventive measures.
Continued process verification not only helps protect consumers from production faults, but business also see benefits in implementing a CPV program.
Should product outputs not match target standards it can be very costly to investigate the problem source without existing CPV data.
[3] A correctly implemented procedure will minimize overreactions to individual production outlier events and guarantee genuine process inconsistency are detected.